Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.49 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31008503 | 1.00 | APP (0.49) | APPHSD17B1HSD17B2MEN1KMT2A | |
| SCHEMBL21476765 | 0.92 | APP (0.56) | APPHSD17B1HSD17B2MEN1KMT2A | |
| SCHEMBL21541891 | 0.89 | APP (0.51) | APPHSD17B1HSD17B2L3MBTL1ESR1 | |
| SCHEMBL30902582 | 0.89 | APP (0.51) | APPHSD17B1HSD17B2L3MBTL1ESR1 | |
| SCHEMBL21476277 | 0.89 | APP (0.57) | APPHSD17B1HSD17B2MEN1KMT2A | |
| SCHEMBL21557143 | 0.87 | APP (0.56) | APPHSD17B1HSD17B2MEN1KMT2A | |
| SCHEMBL31008496 | 0.87 | APP (0.49) | APPHSD17B1HSD17B2SMN1; SMN2ESR1 | |
| SCHEMBL21476442 | 0.87 | APP (0.49) | APPHSD17B1HSD17B2SMN1; SMN2ESR1 | |
| SCHEMBL21557136 | 0.86 | HSD17B1 (0.56) | APPHSD17B1HSD17B2MEN1KMT2A | |
| SCHEMBL21557156 | 0.86 | APP (0.50) | APPHSD17B1HSD17B2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112135822-B | N-heteroarylene compounds with low LUMO energy | 诺瓦尔德股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-3790875-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| EP-3790875-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| EP-3567039-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-05-08 | — | — | EP | disclosed |
| US-20210130336-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-05-06 | — | — | US | disclosed |
| EP-3790875-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2021-03-17 | — | — | EP | disclosed |
| CN-112135822-A | N-heteroarylidenes with low LUMO energy | 诺瓦尔德股份有限公司 | 2020-12-25 | — | — | CN | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| EP-3567039-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2019-11-13 | — | — | EP | disclosed |
| EP-3567039-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2019-11-13 | — | — | EP | disclosed |
| WO-2019198806-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130336-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | L1CAM, MLX, LEF1 | APP 1692/4885HSD17B1 3972/4885HSD17B2 3741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.